COVID-19 Deaths May Have Interfered With Results of CLL Trial
It is unclear whether adding venetoclax to treatment with ibrutinib and obinutuzumab can improve outcomes in older patients with treatment-naïve CLL.
John Schieszer
Contributing Writer
John Schieszer is an award winning medical journalist who produces The Medical Minute podcasts. John received his BA in journalism from the University of Missouri-Columbia School of Journalism and his MA in english from the University of Missouri-St. Louis. In 1990, John was awarded the Case Western Reserve University School of Medicine’s Third Annual Fellowship for Journalists in Biomedical Research. In 1992, he completed a Medical Fellowship at the Marine Biological Laboratories in Woods Hole, Massachusetts.
